Why Treating Hearing Loss With Hearing Aids May Slow Cognitive Decline by Up to 48%

Treating hearing loss with hearing aids may slow cognitive decline by up to 48% in people at highest risk for dementia—but this protective effect isn't...

Treating hearing sits at the center of this dementia and brain health question.

Treating hearing loss with hearing aids may slow cognitive decline by up to 48% in people at highest risk for dementia—but this protective effect isn’t guaranteed for everyone with hearing loss. The landmark ACHIEVE study, the largest randomized controlled trial ever conducted on hearing aids and cognitive health, found that older adults with untreated hearing loss who received hearing aids combined with self-management support and professional audiologist guidance showed measurable slowing of cognitive decline over three years. However, the 48% figure applies specifically to a pre-identified subgroup of 238 participants who had multiple risk factors for cognitive decline, lower baseline cognitive scores, and were already experiencing faster rates of decline. This distinction matters because it tells us that hearing aid intervention offers the greatest protection for people who are already on a concerning cognitive trajectory, not as a blanket prevention strategy for everyone with age-related hearing loss.

This article explores what the research actually shows, who stands to benefit most, how hearing aids might work to protect the brain, and what realistic expectations look like for hearing loss treatment and dementia risk. The connection between hearing and cognition might seem surprising at first, but brain scientists have long suspected that untreated hearing loss strains cognitive resources. When your hearing is poor, your brain works harder just to understand conversations. That extra cognitive load may accelerate decline in people whose cognitive reserves are already depleted. The ACHIEVE study tested whether fixing that hearing problem could meaningfully slow that decline—and for a subset of higher-risk individuals, it did.

Table of Contents

What Does the ACHIEVE Study Actually Reveal About Hearing Aids and Brain Health?

The ACHIEVE (Aging and Cognitive Health Evaluation in Elders) study enrolled 977 older adults between ages 70 and 84, all of whom had untreated hearing loss. Researchers randomly assigned them to receive either hearing aids plus a comprehensive self-management toolkit and ongoing audiologist support, or to a control group that received no intervention. Over a three-year period, researchers tracked changes in cognitive function using standardized tests. The primary results, published in The Lancet in July 2023, were sobering: in the overall study population, hearing aids did not slow cognitive decline compared to controls. Many headlines seized on this as evidence that hearing aids don’t protect the brain—but that conclusion misses the full story.

What the researchers then discovered was more nuanced. Within the ACHIEVE cohort, they identified a pre-specified subgroup of 238 participants from the ARIC (Atherosclerosis Risk in Communities) study who had elevated risk factors for cognitive decline, lower baseline cognitive scores, and were already experiencing faster rates of cognitive deterioration at the study’s start. Within this higher-risk group, hearing intervention slowed cognitive decline by approximately 48%. More recent analysis of this highest-risk quartile, published in 2025, found an even more dramatic effect: 62% slowing of cognitive decline. This progression from 48% to 62% in the highest-risk group suggests the benefit becomes more pronounced as cognitive vulnerability increases. The intervention was not hearing aids alone; it included structured support for habit formation, counseling from audiologists, and tools designed to help older adults stick with treatment and self-manage their hearing health.

What Does the ACHIEVE Study Actually Reveal About Hearing Aids and Brain Health?

Who Actually Benefits from Hearing Aids for Cognitive Protection—and Who Shouldn’t Expect a Brain-Saving Effect?

The critical insight from ACHIEVE is that hearing intervention’s cognitive benefit is not equally distributed. If you have mild hearing loss but no other markers of cognitive vulnerability, hearing aids probably won’t change your trajectory for dementia risk. But if you have hearing loss and you also have hypertension, diabetes, lower scores on cognitive screening tests, or a family history of dementia, or if you’ve recently noticed your thinking is slower than it used to be, you belong in the group where hearing aids showed measurable protective effects. This matters because it reframes hearing aid intervention from a universal brain-health tool to a targeted intervention for people at genuine cognitive risk. Here’s an important limitation: the ACHIEVE results don’t tell us whether hearing aids can prevent cognitive decline in people without pre-existing cognitive risk factors or early signs of decline.

The study was designed to look specifically at cognitive outcomes, not hearing-related quality of life. Many people pursue hearing aids for better social connection, improved communication at family gatherings, or reduced frustration—and those benefits are real and valuable, even if they don’t translate to slower dementia risk. A 75-year-old who wears hearing aids to enjoy book club again, to hear their grandchildren’s voices more clearly, or to participate more fully in conversations is gaining something meaningful. But they shouldn’t expect that their already-normal cognitive trajectory will improve. For people at genuine cognitive risk, however, the stakes are different.

Cognitive Decline Reduction in High-Risk Populations With Hearing InterventionOverall Study Population0% Slowing of Cognitive DeclinePre-Specified High-Risk Subgroup (ARIC)48% Slowing of Cognitive DeclineHighest-Risk Quartile (2025 Analysis)62% Slowing of Cognitive DeclineControl Group (No Treatment)0% Slowing of Cognitive DeclineSource: ACHIEVE Study, Lancet (2023) and PMC/NIH 2025 Secondary Analysis

What’s the Mechanism? How Might Hearing Aids Actually Protect Brain Function?

Researchers have proposed two complementary explanations for why hearing intervention might slow cognitive decline in high-risk individuals. The first is a reduction in cognitive load: when you struggle to hear, your prefrontal cortex—the brain region responsible for attention, memory, and executive function—works overtime just to parse speech. That’s a form of mental exertion that diverts resources from other cognitive processes. By restoring clearer input through hearing aids, you reduce that burden, leaving more cognitive capacity available for thinking, memory, and planning. This is particularly important in people whose cognitive reserves are already depleted by age or early decline.

The second mechanism is social and behavioral. People with untreated hearing loss often withdraw from social interaction because communication becomes effortful and embarrassing. Isolation itself is a known risk factor for cognitive decline—staying mentally and socially engaged appears to be protective. When hearing aids make social participation easier, people naturally increase their engagement with others, their frequency of complex social interactions, and their overall activity levels. This behavioral shift alone could slow cognitive aging. It’s worth noting that both mechanisms likely contribute; the protective effect isn’t simply about the device, but about how the device enables you to function more fully in your daily life.

What's the Mechanism? How Might Hearing Aids Actually Protect Brain Function?

Beyond the Headline—Realistic Expectations and Important Limitations of the Research

The 48% figure, even for the subgroup that benefits, doesn’t mean your cognitive decline will stop or reverse. It means the rate of decline slowed by roughly half compared to people who didn’t receive hearing intervention. If you might have declined significantly over three years without treatment, you might decline more slowly with it. But decline still occurred. Additionally, the ACHIEVE study measured one type of cognitive outcome over three years, and results may look different over longer timeframes or in different populations.

The study participants were relatively healthy older adults; results might differ in people with advanced dementia, severe depression, or other complicating conditions. There’s also a practical limitation: the intervention required consistent use of hearing aids and regular audiologist support. Some people try hearing aids and abandon them because they find them uncomfortable, because they don’t adjust well to the sound, or because they have limited access to ongoing professional support. The study participants received structured counseling and self-management training; a person who gets a hearing aid without that support may not achieve the same results. Additionally, the cognitive protection observed was in people who wore their hearing aids; you won’t gain cognitive benefit from devices sitting unused on a shelf.

Hearing Aids, Dementia Risk, and Quality of Life for People With Cognitive Concerns

For someone who is worried about dementia, receiving a diagnosis of hearing loss can feel like unwelcome news—another thing to manage, another sign of aging. But in the context of cognitive vulnerability, treating hearing loss can feel like taking control. A 78-year-old woman who starts noticing that family members sometimes have to repeat themselves, and who also knows that her mother developed Alzheimer’s disease, might have strong motivation to address her hearing. She’s not just seeking better communication; she’s potentially extending her cognitive healthspan.

That psychological benefit—feeling proactive rather than passive about dementia risk—has its own value. However, there’s an important caveat: hearing aids are one component of cognitive health, not a cure or complete protection against dementia. Someone with treated hearing loss can still develop cognitive decline if they have other risk factors like poor cardiovascular health, untreated depression, cognitive inactivity, or genetic vulnerability. The most realistic picture is that hearing aid treatment is one tool in a broader toolkit for cognitive wellness. It appears to be especially worth pursuing if you’re in a higher-risk group, but it doesn’t replace other evidence-based approaches like cognitive engagement, physical activity, cardiovascular health management, and social connection.

Hearing Aids, Dementia Risk, and Quality of Life for People With Cognitive Concerns

What Else Should People Do Alongside Treating Hearing Loss?

If you’re considering hearing aids as part of a cognitive protection strategy, you’ll likely get better results by combining them with other established approaches to brain health. Physical activity—particularly aerobic exercise—has strong evidence for slowing cognitive decline. Cognitive engagement through reading, puzzles, learning new skills, and intellectually demanding hobbies appears protective. Social connection and participating in group activities, interestingly, may be as important as the activities themselves.

Cardiovascular health matters significantly; conditions like hypertension and diabetes accelerate cognitive decline, and managing them reduces that risk. Someone who gets hearing aids, starts a walking program, joins a book club, and works with their doctor on blood pressure control is taking a more comprehensive approach than hearing aids alone. The ACHIEVE study actually combined hearing aids with a structured self-management toolkit, which suggests that combining the intervention with other self-care practices may enhance results. The “toolkit” included materials designed to help people form habits around hearing aid use, problem-solve challenges, and stay engaged with the process. This combination of sensory restoration (hearing aids) plus behavioral engagement (toolkit, counseling, self-management) might be more protective than either component alone.

The Future of Hearing Intervention and Cognitive Health Research

The ACHIEVE study is landmark research, but it’s also just the beginning of understanding the hearing-cognition connection. Researchers are now investigating whether earlier intervention—treating hearing loss before cognitive decline is noticeable—might prevent decline altogether, not just slow it. They’re also examining whether different types of hearing interventions (advanced hearing aids with artificial intelligence, cochlear implants, bone-conduction devices) might have different cognitive outcomes. Additionally, scientists are exploring whether the cognitive benefits of hearing intervention persist over even longer timeframes, or whether they plateau.

The 2025 secondary analysis showing even stronger protective effects in the highest-risk quartile suggests that continued follow-up research might reveal additional insights. One emerging area of interest is precision medicine for cognitive health. As genetic research advances, researchers may be able to identify which individuals will benefit most from hearing intervention based on genetic factors, baseline cognitive status, hearing loss characteristics, and other biomarkers. This could eventually make it possible to target interventions to the people most likely to benefit, rather than recommending hearing aids broadly to everyone with age-related hearing loss. For now, the takeaway is that hearing loss is worth treating seriously, especially if you have other cognitive risk factors.

Conclusion

The finding that hearing aids may slow cognitive decline by up to 48% is real and significant—but it applies to a specific population: older adults with untreated hearing loss who have other markers of cognitive vulnerability. For this group, hearing aid treatment combined with professional support and self-management coaching offers genuine potential to slow cognitive decline. For people with hearing loss who are not at elevated cognitive risk, hearing aids remain valuable for improving communication, maintaining social engagement, and quality of life, even if cognitive protection isn’t the primary benefit.

The ACHIEVE study shifts our understanding of hearing loss from a peripheral concern (a communication problem) to a potentially meaningful factor in brain aging. If you’re considering hearing aids, the conversation with your doctor or audiologist should include a realistic assessment of your cognitive risk profile. For people at higher risk, treating hearing loss becomes part of a broader strategy for brain health that also includes physical activity, cognitive engagement, cardiovascular management, and social connection. No single intervention prevents or stops dementia, but addressing modifiable risk factors like untreated hearing loss in the context of comprehensive brain-health practices is a practical way to take action when dementia risk concerns you.


You Might Also Like

For more, see NIH MedlinePlus — cognitive testing.

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.